WooGene B&G Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 3.35%

WooGene B&G Co. Ltd (018620) has an Asset Resilience Ratio of 3.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read WooGene B&G Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩3.92 Billion

≈ $2.66 Million USD Cash + Short-term Investments

Total Assets

₩117.10 Billion

≈ $79.36 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how WooGene B&G Co. Ltd's Asset Resilience Ratio has changed over time. See what is WooGene B&G Co. Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down WooGene B&G Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is WooGene B&G Co. Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.92 Billion	3.35%
Total Liquid Assets	₩3.92 Billion	3.35%

Asset Resilience Insights

Limited Liquidity: WooGene B&G Co. Ltd maintains only 3.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

WooGene B&G Co. Ltd Industry Peers by Asset Resilience Ratio

Compare WooGene B&G Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Theragen Etex Co.Ltd KQ:066700	Pharmaceuticals	1.52%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%

Annual Asset Resilience Ratio for WooGene B&G Co. Ltd (2011–2024)

The table below shows the annual Asset Resilience Ratio data for WooGene B&G Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	18.41%	₩20.78 Billion ≈ $14.08 Million	₩112.87 Billion ≈ $76.49 Million	+3.62pp
2023-12-31	14.79%	₩17.98 Billion ≈ $12.18 Million	₩121.58 Billion ≈ $82.39 Million	-12.17pp
2022-12-31	26.96%	₩24.67 Billion ≈ $16.72 Million	₩91.52 Billion ≈ $62.02 Million	+6.31pp
2021-12-31	20.65%	₩15.80 Billion ≈ $10.71 Million	₩76.51 Billion ≈ $51.85 Million	+4.23pp
2020-12-31	16.42%	₩12.74 Billion ≈ $8.63 Million	₩77.56 Billion ≈ $52.56 Million	+9.43pp
2019-12-31	6.99%	₩5.95 Billion ≈ $4.03 Million	₩85.13 Billion ≈ $57.69 Million	+2.52pp
2018-12-31	4.47%	₩2.69 Billion ≈ $1.82 Million	₩60.05 Billion ≈ $40.69 Million	+3.78pp
2017-12-31	0.69%	₩420.69 Million ≈ $285.09K	₩60.64 Billion ≈ $41.09 Million	-9.76pp
2016-12-31	10.45%	₩6.08 Billion ≈ $4.12 Million	₩58.15 Billion ≈ $39.40 Million	+7.98pp
2015-12-31	2.47%	₩1.04 Billion ≈ $706.40K	₩42.24 Billion ≈ $28.63 Million	+2.19pp
2014-12-31	0.28%	₩81.83 Million ≈ $55.46K	₩29.06 Billion ≈ $19.70 Million	-3.00pp
2012-12-31	3.28%	₩858.38 Million ≈ $581.71K	₩26.18 Billion ≈ $17.74 Million	+2.44pp
2011-12-31	0.84%	₩216.00 Million ≈ $146.38K	₩25.81 Billion ≈ $17.49 Million	--

pp = percentage points

About WooGene B&G Co. Ltd

KQ:018620 Korea Pharmaceuticals

Market Cap

$13.13 Million

₩19.37 Billion KRW

Market Cap Rank

#26201 Global

#1952 in Korea

Share Price

₩746.00

Change (1 day)

+4.78%

52-Week Range

₩670.00 - ₩1004.00

All Time High

₩6913.04